All data sharing articles
-
NewsNIH’s new data sharing policy is coming, and it’s a ‘big cultural shift’
The world’s largest public funder of biomedical research will impose broader, deeper, more detailed data management rule on 25 January
-
OpinionBuilding data systems to break down research silos
Shared schemas could make it a lot easier for researchers to cross discipline boundaries
-
ResearchExplainer: How would UK science be affected by a no-deal Brexit?
Access to EU science schemes, freedom of movement and student places are all expected to be disrupted
-
BusinessBrexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
OpinionThe citizen scientists sharing their own data during the Covid-19 pandemic
Groups are using data from wearables and apps to chart the spread of infection
-
BusinessIndustry delves into the digital toolbox
Chemical companies are making their plants and processes increasingly digital, data-driven and interconnected
-
BusinessCleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold
-
NewsNMR standard aims to end raw data headaches
New format can be incorporated into existing software and its makers hope its use will be widespread within a year
-
OpinionWhy you should care about Fair data
The benefits of findable, accessible, interoperable and re-useable information
-
NewsPresentation and copyright worries keep scientists from sharing data
Almost half of researchers surveyed say they don’t know how to present data to make it useful for others
-
NewsResearchGate under pressure to restrict article sharing
International STM publisher group appears poised to take legal action against researchers’ networking site for copyright violations
-
BusinessAnalytical data heads to the cloud
Many manufacturers were launching software instead of instruments at Pittcon
-
-
OpinionLinked data is the future for medicinal chemistry
Paul Groth explains why linked data is starting to revolutionise medicinal chemistry
-
Business
EMA finalises trial transparency rules
Researcher access reinstated, but company redaction rights may cause issues
-
Business
Review says cheaper drug is safe for eye disease
Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar
-
Business
Servier to appear in adverts over lack of transparency
Adverts in the medical press will name French pharma firm for failing to comply with disclosure rules
-
BusinessEMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
Business
Data sharing helps firms reduce Reach animal testing
Alternative in vitro methods slowly gaining traction for some tests
-
Business
AstraZeneca boosts open innovation efforts
Web portal will make collaborative drug discovery easier